Dr. Can Küçük earned his B.S. degree from the Department of Molecular Biology and Genetics at METU. He completed his Ph.D. studies on oncology and cancer biology in 2012 at the UNMC. Having continued post-doctoral studies at UNMC and City of Hope Medical Center for two years, he returned back to Türkiye, and started working at the Medical Biology branch of Dokuz Eylül University and İzmir Biomedicine and Genome Center. Dr. Küçük has publications in prestigious journals such as Lancet Oncology, Blood, PNAS, and Clinical Cancer Research. One of his first author research articles published in Nature Communications was cited as the basic reference for classification of EATL by the WHO. At the international level, he has three awards from the American Society of Hematology (Abstract Achievement Award, Global Research Award, Supplement Award) as well as the International Young Scientist Award from the National Natural Science Foundation of China. At the national level, he earned TÜBA GEBİP and Science Academy BAGEP awards. Importantly, Dr. Küçük mediated access of DEU School of Medicine to invaluable and up-to-date hematology education materials through ASH International Outreach Initiative. He is an editorial board member of BMC Medicine. The research group led by Dr. Küçük focuses on genomic, transcriptomic, and epigenomic aberrations causing lymphoid cancers to identify molecular biomarkers that can facilitate diagnosis, risk stratification, and disease monitoring of lymphoid cancers and to discover more effective therapeutic targets.
- Web Page